JETO Home • Issue Contents

Analysis of volumetric and dosimetric changes in mid-treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy
Amit Bahl, Arun Elangovan, Chinna Babu Dracham, Satinder Kaur, Arun Singh Oinam, Gaurav Trivedi, Roshan Verma, Naresh K Panda and Sushmita Ghoshal

Carcinoma of nasopharynx is a radiosensitive tumor and therapeutic response during radiation treatment can result in dosimetric variations in the delivered dose to the tumor and critical organs. This study was done to evaluate the volumetric and dosimetric changes seen in tumor tissue and organs at risk in a mid treatment planning scan and its implications for adaptive replanning. Twenty patients of locally advanced carcinoma nasopharynx were evaluated. All patients were started on treatment with a baseline treatment plan on SIB-VMAT. To evaluate volumetric and dosimetric changes during treatment, a mid treatment CT scan (MTS) was taken at the 17th fraction of treatment and compared with the baseline planning CT scan (BS). Adaptive treatment plans were generated on the MTS and further treatment was continued on the adaptive plans. The mean weight loss observed at the 17th fraction of treatment was 3.4 ± 2.6 kg(Mean±S.D). The mean neck diameter at C2 level was 14.19±1.02 and 13.29 ± 1.14 cm in the BS and MTS respectively (p=0.001). The GTV 70 volume showed a 29.16% volume loss. The mean doses received by the right and left parotids were 25.45±0.98 and 24.64±3.8 Gy in the baseline treatment plan and 33.21±11.29 (p=0.054) and 31.76±8.44 Gy respectively in the MTS (p=0.016) The mean weight loss showed a statistically significant correlation with increase in the right parotid(p=0.043) and left parotid doses(p=0.024). Weight loss during treatment combined with volume changes in target tissues mandate routine adaptive replanning while treating carcinoma nasopharynx.

Keywords: adaptive, nasopharynx, radiotherapy

Abbreviations: baseline planning CT scan, BS; mid treatment CT scan, MTS; simultaneous integrated boost-volumetric modulated arc therapy, SIB-VMAT; median dose received by 50% volume, D50; mean dose, Dmean; near maximum absorbed dose, D2; near minimum absorbed dose, D98; maximum dose, Dmax; dose received by 1% volume, D1; planning organ at risk volume, PRV

Full Text (IP)